Tri Locum Partners LP Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$329.5B
Holdings
23
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (23 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | TEVATEVA PHARMACEUTICAL INDS LTD | 2,046,846 | $34.3B | 10.41% | |
| 2 | MDGLMADRIGAL PHARMACEUTICALS INC | 97,765 | $29.6B | 8.98% | |
| 3 | ALNYALNYLAM PHARMACEUTICALS INC | 89,525 | $29.2B | 8.86% | |
| 4 | ARGXARGENX SE | 47,793 | $26.3B | 7.99% | |
| 5 | ASNDASCENDIS PHARMA A/S | 147,642 | $25.5B | 7.73% | |
| 6 | SLNOSOLENO THERAPEUTICS INC | 288,880 | $24.2B | 7.34% | |
| 7 | VRNAVERONA PHARMA PLC | 216,578 | $20.5B | 6.22% | |
| 8 | INSPINSPIRE MED SYS INC | 149,244 | $19.4B | 5.88% | |
| 9 | UNHUNITEDHEALTH GROUP INC | 60,584 | $18.9B | 5.74% | |
| 10 | AXSMAXSOME THERAPEUTICS INC | 157,861 | $16.5B | 5.00% | |
| 11 | EOLSEVOLUS INC | 1,239,031 | $11.4B | 3.46% | |
| 12 | ABBVABBVIE INC | 55,661 | $10.3B | 3.14% | |
| 13 | VERAVERA THERAPEUTICS INC | 413,114 | $9.7B | 2.95% | |
| 14 | AVDLAVADEL PHARMACEUTICALS PLC | 1,014,456 | $9.0B | 2.72% | |
| 15 | PRAXPRAXIS PRECISION MEDICINES I | 195,432 | $8.2B | 2.49% | |
| 16 | TARSTARSUS PHARMACEUTICALS INC | 177,656 | $7.2B | 2.18% | |
| 17 | ISRGINTUITIVE SURGICAL INC | 12,824 | $7.0B | 2.11% | |
| 18 | LEGNLEGEND BIOTECH CORP | 173,260 | $6.1B | 1.87% | |
| 19 | NUVLNUVALENT INC | 75,973 | $5.8B | 1.76% | |
| 20 | BHVNBIOHAVEN LTD | 271,367 | $3.8B | 1.16% | |
| 21 | KRROKORRO BIO INC | 139,493 | $3.5B | 1.06% | |
| 22 | WGSGENEDX HOLDINGS CORP | 32,931 | $3.0B | 0.92% | |
| 23 | FEMYFEMASYS INC | 30,606 | $29.6M | 0.01% |